Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung

7680546880163 CH-54688 Lyophilisat
Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung
Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung
Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Durchstechflasche(n)
Galenic form
Lyophilisat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
PRC
500.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
54688
Drug name
Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung
Galenic form
PULPA
ATC Code
L04AA06
Authorization status
Z
Dispensing category
B
First authorization
31/08/1998
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Package details

Description (FR)
CELLCEPT i.v. subst sèche 500 mg flac 4 pce
Description (DE)
CELLCEPT i.v. Trockensub 500 mg Durchstf 4 Stk
Market launch
31/08/1998
Narcotic (BTM)
No

Available generics (4)

Mycophenolat-Mofetil Sandoz, Filmtabletten
GTIN: 7680586740014
CHF 238.75
View
Mycophenolat-Mofetil Sandoz, Kapseln
GTIN: 7680586200013
CHF 259.25
View
Myfenax, Filmtabletten
GTIN: 7680592210051
CHF 238.75
View
Myfenax, Kapseln
GTIN: 7680592200045
CHF 259.25
View